Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review

Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Recro Pharma Inc (Recro) provides contract development and manufacturing organization (CDMO) services. The company harnesses formulation capabilities and proprietary delivery technologies for the development, manufacture, and commercialization of pharmaceutical products of its partners. The company manufactures products such as Ritalin LA, Focalin XR, Verelan PM, Verelan SR and Zohydro ER among others for its commercial partners. The company has a manufacturing facility in Gainesville, Georgia, the US. Recro Pharma is headquartered in Malvern, Pennsylvania, the US.

Recro Pharma Inc Key Recent Developments

Dec 16,2020: Recro announces executive changes
Aug 10,2020: Recro reports second quarter 2020 financial results
May 11,2020: Recro reports first quarter 2020 financial results and provides update on COVID-19 response and impact
Apr 07,2020: Recro Pharma receives loan under Paycheck Protection Program
Mar 04,2020: Recro reports financial results for the year ended 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Section 1 - About the Company
Recro Pharma Inc - Key Facts
Recro Pharma Inc - Key Employees
Recro Pharma Inc - Key Employee Biographies
Recro Pharma Inc - Major Products and Services
Recro Pharma Inc - History
Recro Pharma Inc - Company Statement
Recro Pharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Recro Pharma Inc - Business Description
Recro Pharma Inc - Corporate Strategy
Recro Pharma Inc - SWOT Analysis
SWOT Analysis - Overview
Recro Pharma Inc - Strengths
Recro Pharma Inc - Weaknesses
Recro Pharma Inc - Opportunities
Recro Pharma Inc - Threats
Recro Pharma Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Recro Pharma Inc, Recent Deals Summary
Section 5 Companys Recent Developments
Dec 16, 2020: Recro announces executive changes
Aug 10, 2020: Recro reports second quarter 2020 financial results
May 11, 2020: Recro reports first quarter 2020 financial results and provides update on COVID-19 response and impact
Apr 07, 2020: Recro Pharma receives loan under Paycheck Protection Program
Mar 04, 2020: Recro reports financial results for the year ended 2019
Nov 21, 2019: Recro completes separation of Baudax Bio and becomes a dedicated contract development and manufacturing organization
Nov 13, 2019: Recro Pharma announces effectiveness of Baudax Bio Form 10 Registration Statement
Nov 08, 2019: Recro Pharma reports third quarter 2019 financial results
Aug 08, 2019: Recro Pharma reports second quarter 2019 financial results
May 10, 2019: Recro Pharma reports first quarter 2019 financial results
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Recro Pharma Inc, Key Facts
Recro Pharma Inc, Key Employees
Recro Pharma Inc, Key Employee Biographies
Recro Pharma Inc, Major Products and Services
Recro Pharma Inc, History
Recro Pharma Inc, Subsidiaries
Recro Pharma Inc, Key Competitors
Recro Pharma Inc, Ratios based on current share price
Recro Pharma Inc, Annual Ratios
Recro Pharma Inc, Annual Ratios (Cont...1)
Recro Pharma Inc, Annual Ratios (Cont...2)
Recro Pharma Inc, Interim Ratios
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Recro Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Recro Pharma Inc, Performance Chart (2015 - 2019)
Recro Pharma Inc, Ratio Charts
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review

Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Ocuphire Pharma Inc (OCUP) - Financial and Strategic SWOT Analysis Review

Ocuphire Pharma Inc (Ocuphire Pharma), formerly Rexahn Pharmaceuticals Inc, is an ophthalmic biopharmaceutical company that develops and commercializes medicines to treat eye disorders. It is investigating Nyxol, a preservative-free ophthalmic

USD 300 View Report

PDL BioPharma Inc - Strategic SWOT Analysis Review

PDL BioPharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available